Serveur d'exploration sur l'agrobacterium et la transgénèse

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana.

Identifieur interne : 000120 ( Main/Exploration ); précédent : 000119; suivant : 000121

Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana.

Auteurs : Ee Leen Pang [Malaisie] ; Hadrien Peyret [Royaume-Uni] ; Alex Ramirez [Royaume-Uni] ; Hwei-San Loh [Malaisie] ; Kok-Song Lai [Malaisie] ; Chee-Mun Fang [Malaisie] ; William M. Rosenberg [Royaume-Uni] ; George P. Lomonossoff [Royaume-Uni]

Source :

RBID : pubmed:31057572

Abstract

Dengue fever is currently ranked as the top emerging tropical disease, driven by increased global travel, urbanization, and poor hygiene conditions as well as global warming effects which facilitate the spread of Aedes mosquitoes beyond their current distribution. Today, more than 100 countries are affected most of which are tropical Asian and Latin American nations with limited access to medical care. Hence, the development of a dengue vaccine that is dually cost-effective and able to confer a comprehensive protection is ultimately needed. In this study, a consensus sequence of the antigenic dengue viral glycoprotein domain III (cEDIII) was used aiming to provide comprehensive coverage against all four circulating dengue viral serotypes and potential clade replacement event. Utilizing hepatitis B tandem core technology, the cEDIII sequence was inserted into the immunodominant c/e1 loop region so that it could be displayed on the spike structures of assembled particles. The tandem core particles displaying cEDIII epitopes (tHBcAg-cEDIII) were successfully produced in Nicotiana benthamiana via Agrobacterium-mediated transient expression strategy to give a protein of ∼54 kDa, detected in both soluble and insoluble fractions of plant extracts. The assembled tHBcAg-cEDIII virus-like particles (VLPs) were also visualized from transmission electron microscopy. These VLPs had diameters that range from 32 to 35 nm, presenting an apparent size increment as compared to tHBcAg control particles without cEDIII display (namely tEL). Mice immunized with tHBcAg-cEDIII VLPs showed a positive seroconversion to cEDIII antigen, thereby signifying that the assembled tHBcAg-cEDIII VLPs have successfully displayed cEDIII antigen to the immune system. If it is proven to be successful, tHBcAg-cEDIII has the potential to be developed as a cost-effective vaccine candidate that confers a simultaneous protection against all four infecting dengue viral serotypes.

DOI: 10.3389/fpls.2019.00455
PubMed: 31057572
PubMed Central: PMC6477658


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in
<i>Nicotiana benthamiana</i>
.</title>
<author>
<name sortKey="Pang, Ee Leen" sort="Pang, Ee Leen" uniqKey="Pang E" first="Ee Leen" last="Pang">Ee Leen Pang</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>School of Biosciences, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peyret, Hadrien" sort="Peyret, Hadrien" uniqKey="Peyret H" first="Hadrien" last="Peyret">Hadrien Peyret</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Biological Chemistry, John Innes Centre, Norwich</wicri:regionArea>
<wicri:noRegion>Norwich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramirez, Alex" sort="Ramirez, Alex" uniqKey="Ramirez A" first="Alex" last="Ramirez">Alex Ramirez</name>
<affiliation wicri:level="3">
<nlm:affiliation>iQur Limited, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>iQur Limited, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Loh, Hwei San" sort="Loh, Hwei San" uniqKey="Loh H" first="Hwei-San" last="Loh">Hwei-San Loh</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>School of Biosciences, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kok Song" sort="Lai, Kok Song" uniqKey="Lai K" first="Kok-Song" last="Lai">Kok-Song Lai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang</wicri:regionArea>
<wicri:noRegion>Serdang</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang, Chee Mun" sort="Fang, Chee Mun" uniqKey="Fang C" first="Chee-Mun" last="Fang">Chee-Mun Fang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rosenberg, William M" sort="Rosenberg, William M" uniqKey="Rosenberg W" first="William M" last="Rosenberg">William M. Rosenberg</name>
<affiliation wicri:level="3">
<nlm:affiliation>iQur Limited, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>iQur Limited, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lomonossoff, George P" sort="Lomonossoff, George P" uniqKey="Lomonossoff G" first="George P" last="Lomonossoff">George P. Lomonossoff</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Biological Chemistry, John Innes Centre, Norwich</wicri:regionArea>
<wicri:noRegion>Norwich</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31057572</idno>
<idno type="pmid">31057572</idno>
<idno type="doi">10.3389/fpls.2019.00455</idno>
<idno type="pmc">PMC6477658</idno>
<idno type="wicri:Area/Main/Corpus">000106</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000106</idno>
<idno type="wicri:Area/Main/Curation">000106</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000106</idno>
<idno type="wicri:Area/Main/Exploration">000106</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in
<i>Nicotiana benthamiana</i>
.</title>
<author>
<name sortKey="Pang, Ee Leen" sort="Pang, Ee Leen" uniqKey="Pang E" first="Ee Leen" last="Pang">Ee Leen Pang</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>School of Biosciences, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peyret, Hadrien" sort="Peyret, Hadrien" uniqKey="Peyret H" first="Hadrien" last="Peyret">Hadrien Peyret</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Biological Chemistry, John Innes Centre, Norwich</wicri:regionArea>
<wicri:noRegion>Norwich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramirez, Alex" sort="Ramirez, Alex" uniqKey="Ramirez A" first="Alex" last="Ramirez">Alex Ramirez</name>
<affiliation wicri:level="3">
<nlm:affiliation>iQur Limited, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>iQur Limited, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Loh, Hwei San" sort="Loh, Hwei San" uniqKey="Loh H" first="Hwei-San" last="Loh">Hwei-San Loh</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>School of Biosciences, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kok Song" sort="Lai, Kok Song" uniqKey="Lai K" first="Kok-Song" last="Lai">Kok-Song Lai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang</wicri:regionArea>
<wicri:noRegion>Serdang</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang, Chee Mun" sort="Fang, Chee Mun" uniqKey="Fang C" first="Chee-Mun" last="Fang">Chee-Mun Fang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, Semenyih, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, Semenyih</wicri:regionArea>
<wicri:noRegion>Semenyih</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rosenberg, William M" sort="Rosenberg, William M" uniqKey="Rosenberg W" first="William M" last="Rosenberg">William M. Rosenberg</name>
<affiliation wicri:level="3">
<nlm:affiliation>iQur Limited, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>iQur Limited, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lomonossoff, George P" sort="Lomonossoff, George P" uniqKey="Lomonossoff G" first="George P" last="Lomonossoff">George P. Lomonossoff</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Biological Chemistry, John Innes Centre, Norwich</wicri:regionArea>
<wicri:noRegion>Norwich</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in plant science</title>
<idno type="ISSN">1664-462X</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Dengue fever is currently ranked as the top emerging tropical disease, driven by increased global travel, urbanization, and poor hygiene conditions as well as global warming effects which facilitate the spread of
<i>Aedes</i>
mosquitoes beyond their current distribution. Today, more than 100 countries are affected most of which are tropical Asian and Latin American nations with limited access to medical care. Hence, the development of a dengue vaccine that is dually cost-effective and able to confer a comprehensive protection is ultimately needed. In this study, a consensus sequence of the antigenic dengue viral glycoprotein domain III (cEDIII) was used aiming to provide comprehensive coverage against all four circulating dengue viral serotypes and potential clade replacement event. Utilizing hepatitis B tandem core technology, the cEDIII sequence was inserted into the immunodominant c/e1 loop region so that it could be displayed on the spike structures of assembled particles. The tandem core particles displaying cEDIII epitopes (tHBcAg-cEDIII) were successfully produced in
<i>Nicotiana benthamiana</i>
via
<i>Agrobacterium</i>
-mediated transient expression strategy to give a protein of ∼54 kDa, detected in both soluble and insoluble fractions of plant extracts. The assembled tHBcAg-cEDIII virus-like particles (VLPs) were also visualized from transmission electron microscopy. These VLPs had diameters that range from 32 to 35 nm, presenting an apparent size increment as compared to tHBcAg control particles without cEDIII display (namely tEL). Mice immunized with tHBcAg-cEDIII VLPs showed a positive seroconversion to cEDIII antigen, thereby signifying that the assembled tHBcAg-cEDIII VLPs have successfully displayed cEDIII antigen to the immune system. If it is proven to be successful, tHBcAg-cEDIII has the potential to be developed as a cost-effective vaccine candidate that confers a simultaneous protection against all four infecting dengue viral serotypes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">31057572</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1664-462X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<PubDate>
<Year>2019</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in plant science</Title>
<ISOAbbreviation>Front Plant Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in
<i>Nicotiana benthamiana</i>
.</ArticleTitle>
<Pagination>
<MedlinePgn>455</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fpls.2019.00455</ELocationID>
<Abstract>
<AbstractText>Dengue fever is currently ranked as the top emerging tropical disease, driven by increased global travel, urbanization, and poor hygiene conditions as well as global warming effects which facilitate the spread of
<i>Aedes</i>
mosquitoes beyond their current distribution. Today, more than 100 countries are affected most of which are tropical Asian and Latin American nations with limited access to medical care. Hence, the development of a dengue vaccine that is dually cost-effective and able to confer a comprehensive protection is ultimately needed. In this study, a consensus sequence of the antigenic dengue viral glycoprotein domain III (cEDIII) was used aiming to provide comprehensive coverage against all four circulating dengue viral serotypes and potential clade replacement event. Utilizing hepatitis B tandem core technology, the cEDIII sequence was inserted into the immunodominant c/e1 loop region so that it could be displayed on the spike structures of assembled particles. The tandem core particles displaying cEDIII epitopes (tHBcAg-cEDIII) were successfully produced in
<i>Nicotiana benthamiana</i>
via
<i>Agrobacterium</i>
-mediated transient expression strategy to give a protein of ∼54 kDa, detected in both soluble and insoluble fractions of plant extracts. The assembled tHBcAg-cEDIII virus-like particles (VLPs) were also visualized from transmission electron microscopy. These VLPs had diameters that range from 32 to 35 nm, presenting an apparent size increment as compared to tHBcAg control particles without cEDIII display (namely tEL). Mice immunized with tHBcAg-cEDIII VLPs showed a positive seroconversion to cEDIII antigen, thereby signifying that the assembled tHBcAg-cEDIII VLPs have successfully displayed cEDIII antigen to the immune system. If it is proven to be successful, tHBcAg-cEDIII has the potential to be developed as a cost-effective vaccine candidate that confers a simultaneous protection against all four infecting dengue viral serotypes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pang</LastName>
<ForeName>Ee Leen</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peyret</LastName>
<ForeName>Hadrien</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramirez</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>iQur Limited, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Loh</LastName>
<ForeName>Hwei-San</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>School of Biosciences, University of Nottingham Malaysia, Semenyih, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lai</LastName>
<ForeName>Kok-Song</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fang</LastName>
<ForeName>Chee-Mun</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, Semenyih, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosenberg</LastName>
<ForeName>William M</ForeName>
<Initials>WM</Initials>
<AffiliationInfo>
<Affiliation>iQur Limited, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lomonossoff</LastName>
<ForeName>George P</ForeName>
<Initials>GP</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>BBS/E/J/00000166</GrantID>
<Acronym>BB_</Acronym>
<Agency>Biotechnology and Biological Sciences Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>BBS/E/J/0000A182</GrantID>
<Acronym>BB_</Acronym>
<Agency>Biotechnology and Biological Sciences Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>04</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Plant Sci</MedlineTA>
<NlmUniqueID>101568200</NlmUniqueID>
<ISSNLinking>1664-462X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">dengue envelope glycoprotein</Keyword>
<Keyword MajorTopicYN="N">dengue vaccine</Keyword>
<Keyword MajorTopicYN="N">envelope glycoprotein domain III</Keyword>
<Keyword MajorTopicYN="N">epitope display</Keyword>
<Keyword MajorTopicYN="N">hepatitis B core antigen</Keyword>
<Keyword MajorTopicYN="N">tandem core technology</Keyword>
<Keyword MajorTopicYN="N">virus-like particles</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>03</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31057572</ArticleId>
<ArticleId IdType="doi">10.3389/fpls.2019.00455</ArticleId>
<ArticleId IdType="pmc">PMC6477658</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1915-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10051569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2000 Oct 25;276(2):364-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11040127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Aug;75(16):7769-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11462053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Microbiol. 2003 Sep;11(9):438-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13678860</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Cell Biol. 2004 Oct;82(5):506-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15479436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2004 Nov;32(Pt 5):663-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15493982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin. 2008 Jan-Feb;4(1):5-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18438104</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbes Infect. 2009 Feb;11(2):288-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19114121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Biotechnol J. 2009 Sep;7(7):682-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19627561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Genes. 2010 Feb;40(1):53-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19885726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21079655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Rep. 2011 Aug;38(6):3731-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21107723</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biotechnol Adv. 2011 Mar-Apr;29(2):239-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21146601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biotechnol J. 2011 Jun;6(6):650-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21567958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2011 Jun 30;8:333</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21714940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(8):e23319</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21826249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 1990 Oct;3(4):376-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2224837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nanobiotechnology. 2012 Jul 13;10:30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22794664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2012;6(8):e1760</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22880140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2013 Jan;1834(1):221-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23009809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods Enzymol. 2012;517:185-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23084939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Jan 30;31(6):873-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23261049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2013;19(31):5564-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23394559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Apr 25;496(7446):504-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23563266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 May 23;8(5):e64595</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23717637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vis Exp. 2013 Jul 23;(77):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23913006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Ecol Epidemiol. 2013 Aug 30;3:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24003364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Evol Biol. 2013 Sep 28;13:213</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24073945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Plant Sci. 2013 Dec 18;4:519</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24391655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2014 Jul;159(7):1629-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24420159</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1987 Nov 26-Dec 2;330(6146):381-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2446137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vis Exp. 2014 Apr 19;(86):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24796351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Med Int Health. 2014 Sep;19(9):1116-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24889501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Drug Deliv Rev. 2015 Oct 1;93:42-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25451136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Biotechnol. 2015 Apr;32:163-170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25578557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Apr 01;10(4):e0120751</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25830365</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2015 Dec 1;225:59-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26384758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Anal Chem (Palo Alto Calif). 2016 Jun 12;9(1):271-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27049632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Trop Med. 2016 Apr;9(4):395-401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27086160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Trop Med Hyg. 1989 Apr;40(4):444-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2712199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Mol Biol. 2016 Oct;92(3):347-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27566485</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biotechnol Rep (Amst). 2015 Dec 07;9:15-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28352588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Biotechnol J. 2017 Dec;15(12):1590-1601</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28421694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Trop Med. 2017 Mar;10(3):220-228</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28442105</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2017 May 8;11(5):e0005584</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28481883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Aug 9;7(1):7679</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28794424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Virol. 2017 Oct;26:81-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28800551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2018 Feb 1;36(6):873-880</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29306508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 1984 Nov;9(3):249-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6520198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1994 Jun 17;77(6):943-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8004680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1997 Aug;78 ( Pt 8):1861-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9266980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1999 Jan 8;442(1):1-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9923592</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Malaisie</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="Malaisie">
<noRegion>
<name sortKey="Pang, Ee Leen" sort="Pang, Ee Leen" uniqKey="Pang E" first="Ee Leen" last="Pang">Ee Leen Pang</name>
</noRegion>
<name sortKey="Fang, Chee Mun" sort="Fang, Chee Mun" uniqKey="Fang C" first="Chee-Mun" last="Fang">Chee-Mun Fang</name>
<name sortKey="Lai, Kok Song" sort="Lai, Kok Song" uniqKey="Lai K" first="Kok-Song" last="Lai">Kok-Song Lai</name>
<name sortKey="Loh, Hwei San" sort="Loh, Hwei San" uniqKey="Loh H" first="Hwei-San" last="Loh">Hwei-San Loh</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Peyret, Hadrien" sort="Peyret, Hadrien" uniqKey="Peyret H" first="Hadrien" last="Peyret">Hadrien Peyret</name>
</noRegion>
<name sortKey="Lomonossoff, George P" sort="Lomonossoff, George P" uniqKey="Lomonossoff G" first="George P" last="Lomonossoff">George P. Lomonossoff</name>
<name sortKey="Ramirez, Alex" sort="Ramirez, Alex" uniqKey="Ramirez A" first="Alex" last="Ramirez">Alex Ramirez</name>
<name sortKey="Rosenberg, William M" sort="Rosenberg, William M" uniqKey="Rosenberg W" first="William M" last="Rosenberg">William M. Rosenberg</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/AgrobacTransV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000120 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000120 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    AgrobacTransV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31057572
   |texte=   Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31057572" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AgrobacTransV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Nov 20 15:45:55 2020. Site generation: Wed Mar 6 15:24:41 2024